128 related articles for article (PubMed ID: 20643483)
1. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
[TBL] [Abstract][Full Text] [Related]
2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
Perlis RH; Purcell S; Fagerness J; Cusin C; Yamaki L; Fava M; Smoller JW
Biol Psychiatry; 2007 Sep; 62(5):536-40. PubMed ID: 17300755
[TBL] [Abstract][Full Text] [Related]
4. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
[TBL] [Abstract][Full Text] [Related]
5. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
6. [Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder].
Liu XH; Xu YF; Cui DH; Jiang SD; Qian YP; Yu SY; Jiang KD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):263-6. PubMed ID: 20533262
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
8. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
[TBL] [Abstract][Full Text] [Related]
9. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
[TBL] [Abstract][Full Text] [Related]
10. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
[TBL] [Abstract][Full Text] [Related]
11. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.
Rosenhagen MC; Uhr M
J Clin Psychopharmacol; 2010 Apr; 30(2):209-11. PubMed ID: 20520302
[No Abstract] [Full Text] [Related]
13. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.
Juhasz G; Dunham JS; McKie S; Thomas E; Downey D; Chase D; Lloyd-Williams K; Toth ZG; Platt H; Mekli K; Payton A; Elliott R; Williams SR; Anderson IM; Deakin JF
Biol Psychiatry; 2011 Apr; 69(8):762-71. PubMed ID: 21215389
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
[TBL] [Abstract][Full Text] [Related]
16. Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
Serretti A; Chiesa A; Crisafulli C; Massat I; Linotte S; Calati R; Kasper S; Bailer U; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Neuropsychobiology; 2012; 65(2):70-5. PubMed ID: 22222462
[TBL] [Abstract][Full Text] [Related]
17. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
18. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly.
Cerri AP; Arosio B; Viazzoli C; Confalonieri R; Vergani C; Annoni G
Int J Geriatr Psychiatry; 2010 Mar; 25(3):219-23. PubMed ID: 19618378
[TBL] [Abstract][Full Text] [Related]
19. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
20. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
